QuidelOrtho (QDEL) Operating Expenses (2021 - 2024)

QuidelOrtho has disclosed Operating Expenses across 4 years of filings, most recently posting $286.5 million for Q1 2024.

• Operating Expenses for Q1 2024 came in at $286.5 million, down 2.68% year-over-year; the trailing twelve-month figure through Dec 2024 was $286.5 million (down 78.33% YoY), and the FY2024 annual result was $1.1 billion, down 0.79% from the prior year.
• Operating Expenses came in at $286.5 million for Q1 2024 at QuidelOrtho, down from $478.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $707.6 million in Q1 2023 to a low of $77.9 million in Q3 2021.
• The 4-year median for Operating Expenses is $283.0 million (2023), against an average of $284.0 million.
• Across the five-year window, Operating Expenses jumped 241.64% in 2022 and tumbled 32.39% in 2023, its largest moves.
• QuidelOrtho's Operating Expenses stood at $86.7 million in 2021, then surged by 241.64% to $296.2 million in 2022, then surged by 61.51% to $478.4 million in 2023, then sank by 40.11% to $286.5 million in 2024.
• The last three Operating Expenses figures came in at $286.5 million (Q1 2024), $478.4 million (Q4 2023), and $283.0 million (Q4 2023), per Business Quant data.